• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性低钙血症性高钙血症患者佝偻病的非典型骨骼表现。

Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient.

作者信息

Wu Bo, Wang Ou, Jiang Yan, Li Mei, Xing Xiaoping, Xia Weibo

机构信息

Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Bone Res. 2017 Jun 27;5:17001. doi: 10.1038/boneres.2017.1. eCollection 2017.

DOI:10.1038/boneres.2017.1
PMID:28690912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5486235/
Abstract

Familial hypocalciuric hypercalcemia (FHH) is caused by inactivating mutations in the calcium-sensing receptor () gene. The loss of function of presents with rickets as the predominant skeletal abnormality in mice, but is rarely reported in humans. Here we report a case of a 16-year-old boy with FHH who presented with skeletal manifestations of rickets. To identify the possible pathogenic mutation, the patient was evaluated clinically, biochemically, and radiographically. The patient and his family members were screened for genetic mutations. Physical examination revealed a pigeon breast deformity and X-ray examinations showed epiphyseal broadening, both of which indicate rickets. Biochemical tests also showed increased parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, and elevated ionized calcium. Based on these results, a diagnosis of FHH was suspected. Sequence analysis of the patient's gene revealed a new missense mutation (c.2279T>A) in exon 7, leading to the damaging amino change (p.I760N) in the mature CaSR protein, confirming the diagnosis of FHH. Moreover, the skeletal abnormities may be related to but not limited to vitamin D abnormity. Elevated PTH levels and a rapid skeletal growth period in adolescence may have also contributed. Our study revealed that rickets-like features have a tendency to present atypically in FHH patients who have a mild vitamin D deficiency, and that mutations may have a partial role in the pathogenesis of skeletal deformities.

摘要

家族性低钙血症性高钙血症(FHH)由钙敏感受体(CaSR)基因的失活突变引起。在小鼠中,CaSR功能丧失主要表现为佝偻病这一骨骼异常,但在人类中鲜有报道。本文报告一例16岁患FHH的男孩,其表现出佝偻病的骨骼症状。为确定可能的致病突变,对该患者进行了临床、生化及影像学评估。对患者及其家庭成员进行了基因突变筛查。体格检查发现鸡胸畸形,X线检查显示骨骺增宽,均提示佝偻病。生化检查还显示甲状旁腺激素(PTH)、1,25 - 二羟维生素D升高,离子钙水平升高。基于这些结果,怀疑为FHH。对患者CaSR基因的序列分析显示外显子7有一个新的错义突变(c.2279T>A),导致成熟CaSR蛋白中出现有害的氨基酸变化(p.I760N),从而确诊FHH。此外,骨骼异常可能与维生素D异常有关,但不限于维生素D异常。青春期PTH水平升高及骨骼快速生长期可能也起了作用。我们的研究表明,在维生素D轻度缺乏的FHH患者中,佝偻病样特征往往表现不典型,且CaSR突变可能在骨骼畸形的发病机制中起部分作用。

相似文献

1
Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient.家族性低钙血症性高钙血症患者佝偻病的非典型骨骼表现。
Bone Res. 2017 Jun 27;5:17001. doi: 10.1038/boneres.2017.1. eCollection 2017.
2
A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.一种导致家族性低尿钙性高钙血症(FHH)表型的纯合性钙敏感受体(CaSR)突变被维生素D缺乏完全掩盖,表现为佝偻病。
J Clin Endocrinol Metab. 2014 Jun;99(6):E1146-53. doi: 10.1210/jc.2013-3593. Epub 2014 Feb 11.
3
Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.钙敏感受体(CaSR)中存在假定的新致病性突变,导致甲状旁腺激素依赖性家族性高钙血症伴低甲状旁腺激素水平。
Osteoporos Int. 2020 Jan;31(1):203-207. doi: 10.1007/s00198-019-05170-9. Epub 2019 Oct 23.
4
A Novel Missense Gene Sequence Variation Resulting in Familial Hypocalciuric Hypercalcemia.一种导致家族性低钙血症性高钙血症的新型错义基因序列变异。
AACE Clin Case Rep. 2022 May 17;8(5):194-198. doi: 10.1016/j.aace.2022.05.002. eCollection 2022 Sep-Oct.
5
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进症中的血浆25-羟维生素D、1,25-二羟维生素D和甲状旁腺激素
Eur J Endocrinol. 2008 Dec;159(6):719-27. doi: 10.1530/EJE-08-0440. Epub 2008 Sep 11.
6
Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.家族性低钙尿性高钙血症在一个男性索引病例中的表现:在 13 年的临床随访中,与原发性甲状旁腺功能亢进症进行鉴别诊断的灰色地带。
Physiol Res. 2020 Sep 30;69(Suppl 2):S321-S328. doi: 10.33549/physiolres.934522.
7
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population.对临床疑似家族性低钙血症性高钙血症患者钙敏感受体基因的分子遗传学分析:丹麦人群中的表型变异和突变谱
J Clin Endocrinol Metab. 2007 Nov;92(11):4373-9. doi: 10.1210/jc.2007-0322. Epub 2007 Aug 14.
8
Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.家族性低钙血症性高钙血症中钙敏感受体基因新突变的鉴定及功能特征:维生素D状态对临床严重程度的调节作用
J Clin Endocrinol Metab. 2007 Jul;92(7):2616-23. doi: 10.1210/jc.2007-0123. Epub 2007 May 1.
9
Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.高钙血症伴低钙尿症患者中钙敏感受体相关基因突变作为与原发性甲状旁腺功能亢进症的鉴别诊断:在意大利人群中检测到两个新的失活突变
Nephrol Dial Transplant. 2014 Oct;29(10):1902-9. doi: 10.1093/ndt/gfu065. Epub 2014 Aug 7.
10
Think twice: a rare calcium sensing receptor mutation and a new diagnosis of familial hypocalciuric hypercalcaemia.三思而后行:一种罕见的钙敏感受体突变与家族性低钙血症性高钙血症的新诊断
Endocrinol Diabetes Metab Case Rep. 2020 Jun 22;2020. doi: 10.1530/EDM-20-0004.

引用本文的文献

1
A Novel Variant in the Calcium-Sensing Receptor Associated with Familial Hypocalciuric Hypercalcemia and Low-to-Normal PTH.一种与家族性低钙血症性高钙血症及低至正常甲状旁腺激素相关的钙敏感受体新变异体。
Case Rep Endocrinol. 2020 Sep 30;2020:8752610. doi: 10.1155/2020/8752610. eCollection 2020.
2
Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis.构建三维模型以模拟癌症骨转移动态微环境的工程方法。
Bone Res. 2018 Feb 26;6:3. doi: 10.1038/s41413-018-0008-9. eCollection 2018.

本文引用的文献

1
Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).钙敏感受体(CaSR)突变基因敲入小鼠模拟常染色体显性低钙血症(ADH)的异常,钙敏调节剂可改善这些异常。
J Bone Miner Res. 2015 Nov;30(11):1980-93. doi: 10.1002/jbmr.2551. Epub 2015 Jul 16.
2
The high prevalence of hypovitaminosis D in China: a multicenter vitamin D status survey.中国维生素D缺乏症的高患病率:一项多中心维生素D状况调查。
Medicine (Baltimore). 2015 Feb;94(8):e585. doi: 10.1097/MD.0000000000000585.
3
Receptor expression modulates calcium-sensing receptor mediated intracellular Ca2+ mobilization.
受体表达调节钙敏感受体介导的细胞内钙离子动员。
Endocrinology. 2015 Apr;156(4):1330-42. doi: 10.1210/en.2014-1771. Epub 2015 Jan 21.
4
Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization.由GNA11基因种系突变引起的常染色体显性遗传性甲状旁腺功能减退症:表型和分子特征
J Clin Endocrinol Metab. 2014 Sep;99(9):E1774-83. doi: 10.1210/jc.2014-1029. Epub 2014 May 13.
5
A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.一种导致家族性低尿钙性高钙血症(FHH)表型的纯合性钙敏感受体(CaSR)突变被维生素D缺乏完全掩盖,表现为佝偻病。
J Clin Endocrinol Metab. 2014 Jun;99(6):E1146-53. doi: 10.1210/jc.2013-3593. Epub 2014 Feb 11.
6
Primary hyperparathyroidism masquerading as rickets: diagnostic challenge and treatment outcomes.伪装成佝偻病的原发性甲状旁腺功能亢进症:诊断挑战与治疗结果
J Clin Res Pediatr Endocrinol. 2013;5(4):266-9. doi: 10.4274/Jcrpe.1060.
7
A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing.应用靶向二代测序技术在一名 citrin 缺陷症中国患者中发现 SLC25A13 基因的一种新突变。
Gene. 2014 Jan 10;533(2):547-53. doi: 10.1016/j.gene.2013.10.021. Epub 2013 Oct 23.
8
Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.钙敏感受体(CaSR)突变与钙、电解质和水代谢紊乱。
Best Pract Res Clin Endocrinol Metab. 2013 Jun;27(3):359-71. doi: 10.1016/j.beem.2013.04.007. Epub 2013 May 18.
9
Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways.钙敏感受体(CaSR):药理学特性和信号通路。
Best Pract Res Clin Endocrinol Metab. 2013 Jun;27(3):315-31. doi: 10.1016/j.beem.2013.05.010. Epub 2013 Jun 17.
10
The CASR gene: alternative splicing and transcriptional control, and calcium-sensing receptor (CaSR) protein: structure and ligand binding sites.CASR 基因:选择性剪接和转录调控,以及钙敏感受体(CaSR)蛋白:结构和配体结合位点。
Best Pract Res Clin Endocrinol Metab. 2013 Jun;27(3):285-301. doi: 10.1016/j.beem.2013.02.009. Epub 2013 Mar 27.